These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 23763455)

  • 1. Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis.
    Mohamadnejad M; Alimoghaddam K; Bagheri M; Ashrafi M; Abdollahzadeh L; Akhlaghpoor S; Bashtar M; Ghavamzadeh A; Malekzadeh R
    Liver Int; 2013 Nov; 33(10):1490-6. PubMed ID: 23763455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of allogeneic mesenchymal stem cell transplantation in the treatment of liver cirrhosis caused by autoimmune diseases.
    Liang J; Zhang H; Zhao C; Wang D; Ma X; Zhao S; Wang S; Niu L; Sun L
    Int J Rheum Dis; 2017 Sep; 20(9):1219-1226. PubMed ID: 28217916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot study of umbilical cord-derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis.
    Wang L; Li J; Liu H; Li Y; Fu J; Sun Y; Xu R; Lin H; Wang S; Lv S; Chen L; Zou Z; Li B; Shi M; Zhang Z; Wang FS
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():85-92. PubMed ID: 23855301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous bone marrow-derived mesenchymal stem cell transplantation promotes liver regeneration after portal vein embolization in cirrhotic rats.
    Li T; Zhu J; Ma K; Liu N; Feng K; Li X; Wang S; Bie P
    J Surg Res; 2013 Oct; 184(2):1161-73. PubMed ID: 23809154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients.
    Zhang Z; Lin H; Shi M; Xu R; Fu J; Lv J; Chen L; Lv S; Li Y; Yu S; Geng H; Jin L; Lau GK; Wang FS
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():112-20. PubMed ID: 22320928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial).
    Mathiasen AB; Jørgensen E; Qayyum AA; Haack-Sørensen M; Ekblond A; Kastrup J
    Am Heart J; 2012 Sep; 164(3):285-91. PubMed ID: 22980293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease.
    Salama H; Zekri AR; Medhat E; Al Alim SA; Ahmed OS; Bahnassy AA; Lotfy MM; Ahmed R; Musa S
    Stem Cell Res Ther; 2014 May; 5(3):70. PubMed ID: 24886681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency.
    Zekri AR; Salama H; Medhat E; Musa S; Abdel-Haleem H; Ahmed OS; Khedr HA; Lotfy MM; Zachariah KS; Bahnassy AA
    Stem Cell Res Ther; 2015 Jun; 6(1):118. PubMed ID: 26062731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial.
    Kharaziha P; Hellström PM; Noorinayer B; Farzaneh F; Aghajani K; Jafari F; Telkabadi M; Atashi A; Honardoost M; Zali MR; Soleimani M
    Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1199-205. PubMed ID: 19455046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: regulation of Treg/Th17 cells.
    Xu L; Gong Y; Wang B; Shi K; Hou Y; Wang L; Lin Z; Han Y; Lu L; Chen D; Lin X; Zeng Q; Feng W; Chen Y
    J Gastroenterol Hepatol; 2014 Aug; 29(8):1620-8. PubMed ID: 24942592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of autologous mesenchymal stem cell transplantation in patients with liver cirrhosis.
    Kantarcıoğlu M; Demirci H; Avcu F; Karslıoğlu Y; Babayiğit MA; Karaman B; Öztürk K; Gürel H; Akdoğan Kayhan M; Kaçar S; Kubar A; Öksüzoğlu G; Ural AU; Bağcı S
    Turk J Gastroenterol; 2015 May; 26(3):244-50. PubMed ID: 26006200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis.
    Mohamadnejad M; Alimoghaddam K; Mohyeddin-Bonab M; Bagheri M; Bashtar M; Ghanaati H; Baharvand H; Ghavamzadeh A; Malekzadeh R
    Arch Iran Med; 2007 Oct; 10(4):459-66. PubMed ID: 17903050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes.
    Peng L; Xie DY; Lin BL; Liu J; Zhu HP; Xie C; Zheng YB; Gao ZL
    Hepatology; 2011 Sep; 54(3):820-8. PubMed ID: 21608000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prospective controlled trial of safety of human umbilical cord derived-mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis].
    Lin H; Zhang Z; Shi M; Xu RN; Fu JL; Geng H; Li YY; Yu SJ; Chen LM; Lv S; Wang FS
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jul; 20(7):487-91. PubMed ID: 23044231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial.
    Suk KT; Yoon JH; Kim MY; Kim CW; Kim JK; Park H; Hwang SG; Kim DJ; Lee BS; Lee SH; Kim HS; Jang JY; Lee CH; Kim BS; Jang YO; Cho MY; Jung ES; Kim YM; Bae SH; Baik SK
    Hepatology; 2016 Dec; 64(6):2185-2197. PubMed ID: 27339398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of autologous bone marrow-derived liver stem cells transplantation in hepatitis B virus-induced liver cirrhosis.
    Liao X; AnCheng JY; Zhou QJ; Liao C
    Hepatogastroenterology; 2013 May; 60(123):406-9. PubMed ID: 23178469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraportal Infusion of Bone Marrow Mononuclear or CD133+ Cells in Patients With Decompensated Cirrhosis: A Double-Blind Randomized Controlled Trial.
    Mohamadnejad M; Vosough M; Moossavi S; Nikfam S; Mardpour S; Akhlaghpoor S; Ashrafi M; Azimian V; Jarughi N; Hosseini SE; Moeininia F; Bagheri M; Sharafkhah M; Aghdami N; Malekzadeh R; Baharvand H
    Stem Cells Transl Med; 2016 Jan; 5(1):87-94. PubMed ID: 26659833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study.
    Amin MA; Sabry D; Rashed LA; Aref WM; el-Ghobary MA; Farhan MS; Fouad HA; Youssef YA
    Clin Transplant; 2013; 27(4):607-12. PubMed ID: 23923970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone-marrow-derived cells cultured in serum-free medium reduce liver fibrosis and improve liver function in carbon-tetrachloride-treated cirrhotic mice.
    Iwamoto T; Terai S; Hisanaga T; Takami T; Yamamoto N; Watanabe S; Sakaida I
    Cell Tissue Res; 2013 Mar; 351(3):487-95. PubMed ID: 23183782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of mesenchymal stem cells in multiple system atrophy.
    Lee PH; Lee JE; Kim HS; Song SK; Lee HS; Nam HS; Cheong JW; Jeong Y; Park HJ; Kim DJ; Nam CM; Lee JD; Kim HO; Sohn YH
    Ann Neurol; 2012 Jul; 72(1):32-40. PubMed ID: 22829267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.